INS and diabetes mellitus: The study has shown statistically significant differences in mean visfatin concentrations between patients with diabetes mellitus type 2 treated with metformin and patients with diabetes mellitus type 2 treated with insulin, respectively (21.3 ng/ml, 28.4 ng/ml).